Legal and Regulatory Barriers to Medical Psilocybin Use: An International Overview
OpenAlex – October 02, 2025
Source: OpenAlex
Summary
Psilocybin shows immense promise for treating psychiatric and neurological disorders. Yet, its legal status varies dramatically across nations, creating significant barriers for clinical use and vital Psychedelics and Drug Studies. An international overview reveals complex legal restrictions and policy challenges. Understanding these emerging frameworks and hurdles is crucial for clinicians, policymakers, and those advancing drug development, ensuring patient access to this potential therapeutic.
Abstract
Psilocybin has emerged as a promising therapeutic agent for psychiatric and neurological disorders. However, its legal status varies significantly across countries, creating barriers for clinical use and research. This paper provides an international overview of the regulatory landscape governing medical psilocybin, highlighting key legal restrictions, policy challenges, and emerging frameworks that support clinical trials and compassionate use. Understanding these barriers is crucial for clinicians, researchers, and policymakers.